- Home
- DWSN vs GALT Comparison
DWSN vs GALT Comparison
Compare DWSN & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DWSN
- GALT
- Stock Information
- Founded
- DWSN 1952
- GALT 2000
- Country
- DWSN United States
- GALT United States
- Employees
- DWSN N/A
- GALT N/A
- Industry
- DWSN Oil & Gas Production
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- DWSN Energy
- GALT Health Care
- Exchange
- DWSN Nasdaq
- GALT Nasdaq
- Market Cap
- DWSN 89.9M
- GALT 83.5M
- IPO Year
- DWSN N/A
- GALT N/A
- Fundamental
- Price
- DWSN $1.48
- GALT $3.60
- Analyst Decision
- DWSN
- GALT Buy
- Analyst Count
- DWSN 0
- GALT 2
- Target Price
- DWSN N/A
- GALT $6.00
- AVG Volume (30 Days)
- DWSN 159.9K
- GALT 309.6K
- Earning Date
- DWSN 08-11-2025
- GALT 08-12-2025
- Dividend Yield
- DWSN N/A
- GALT N/A
- EPS Growth
- DWSN N/A
- GALT N/A
- EPS
- DWSN N/A
- GALT N/A
- Revenue
- DWSN $58,648,000.00
- GALT N/A
- Revenue This Year
- DWSN N/A
- GALT N/A
- Revenue Next Year
- DWSN N/A
- GALT N/A
- P/E Ratio
- DWSN N/A
- GALT N/A
- Revenue Growth
- DWSN N/A
- GALT N/A
- 52 Week Low
- DWSN $1.08
- GALT $0.73
- 52 Week High
- DWSN $5.54
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- DWSN 49.73
- GALT 77.43
- Support Level
- DWSN $1.41
- GALT $2.54
- Resistance Level
- DWSN $1.60
- GALT $3.15
- Average True Range (ATR)
- DWSN 0.12
- GALT 0.27
- MACD
- DWSN 0.01
- GALT 0.05
- Stochastic Oscillator
- DWSN 40.91
- GALT 88.64
About DWSN Dawson Geophysical Company
Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.